干扰素诱生剂刺激肝细胞产生细胞因子研究
摘要
目的
在体外模型研究肝细胞能否被诱导产生干扰素等细胞因子,探讨肝细胞在乙型肝炎病毒清除过程中可能发挥的作用。
方法
选用聚肌胞(polyI:C)、植物血凝素(PHA)与结核菌素纯蛋白衍生物(PPD)为细胞因子诱生剂,以诱生剂最大无毒浓度刺激HepG2细胞及2.2.15细胞,分别以无细胞因子诱生剂作用的HepG2细胞及2.2.15细胞为对照组,用双抗体夹心ELlSA法检测细胞上清液及细胞裂解液中24小时、48小时IFN-α、TNF-α与IFN-γ的含量,并检测了2.2.15细胞被细胞因子诱生剂刺激后24小时、48小时细胞上清液及细胞裂解液中的HBV病毒标志物sAg、eAg的含量。
结果
1. PPD、polyI:C、PHA以最大无毒浓度分别是10μg/ml、20μg/ml、30μg/ml;刺激HepG2后24hr,48 hr时点HepG2培养上清液及裂解液中均能产生IFN-α,与对照组比较有显著性差异,其含量48hr时点大于24hr时点,胞内、胞外含量有显著性差异; PPD、polyI:C与PHA刺激HepG2后,细胞上清液及裂解液均检测出TNF-α,但与对照组比较无显著性差异,胞内胞外含量无显著性差异,不同时点间亦无显著性差异; PPD、PHA、PoLyI:C刺激后上清液中均检出IFN-γ,但与对照组比较无显著性差异,PPD、PHA刺激后细胞培养裂解液中检测出IFN-γ,与对照组比较有显著性差异,胞内、胞外含量有显著性差异;PoLyI:C刺激后培养细胞裂解液中检出IFN-γ,但与对照组比较无显著性差异,不同时点间无显著性差异;
2. PPD、polyI:C、PHA以最大无毒浓度,刺激2.2.15细胞后,细胞裂解液、上清液均检测出IFN-α,与对照组比较有显著性差异,胞内含量比胞外含量多,有显著性差异,不同时点间无显著性差异;细胞裂解液、上清液中均检出IFN-γ、TFN-α;但与对照组比较无显著性差异,胞内含量与胞外含量比,无显著性差异,不同时点间无显著性差异;
3. PPD、polyI:C、PHA以最大无毒浓度,刺激2.2.15细胞,细胞裂解液、上清液清除sAg、eAg的效果与对照组相比无显著性差异。
结论
1. PPD、polyI:C、PHA能够刺激HepG2细胞产生IFN-α并分泌至胞外,且IFN-α的量与诱生剂作用时间成正比。PPD、PHA能刺激HepG2细胞产生IFN-γ,但未能或未及分泌至胞外,IFN-γ的量与诱生剂作用时间长短无关。polyI:C刺激HepG2细胞产生IFN-γ作用不明显;另外,三种诱生剂刺激HepG2产生TNF-α作用也不明显。
2. PPD、polyI:C、PHA,刺激2.2.15细胞后,能产生IFN-α,并分泌至胞外,但IFN-α的量与诱生剂作用时间长短无关;三种诱生剂刺激2.2.15细胞产生IFN-γ、TNF-α作用均不明显。
3. PPD、polyI:C、PHA,刺激2.2.15细胞,清除sAg、eAg的效果不明显。
Objective
To investgate if cytokines can be Induced by cytokine Inducer in hepatocytes in vitro.
Methods
HepG2 and 2.2.15 Cells were treated with maximal tolerance dosage of polyI:C ,PHA, and PPD. After 24h and 48h ,the contents of IFN-α、TNF-αand IFN-γboth in the supernatant and cell were determined by ELISA, and the contents of HBV virus marker sAg、eAg in 2.2.15 Cells in the supernatant and cell were also determined by ELISA.
Results
1、IFN-αwere detected in the supernatant and lysate in 24h and 48h,IFN-αlevels were significantly higher than that of control groups,IFN-αlevels in 24h were significantly higher than in 48h,IFN-αlevels in intra-cell and ecto-cell were significant difference。HepG2 were treated with PPD、polyI:C and PHA, TNF-αwere detected in the supernatant and lysate, The difference of TNF-αlevels were not significant with control groups,The difference of IFN-αlevels in intra-cell and ecto-cell were not significant. The difference of IFN-αlevels in 24h and 48h were not significant. HepG2 were treated with PPD、polyI:C and PHA , IFN-γwere detected in the supernatant ,The difference of IFN-γlevels were not significant with control groups,HepG2 were treated with PPD and PHA,IFN-γwere detected in the lysate,The difference of IFN-γlevels were not significant with control groups,The difference of IFN-γlevels in 24h and 48h were not significant.
2. 2.2.15cells were treated with PPD、polyI:C and PHA with the maximal tolerance dosage,IFN-αwere detected in the supernatant and lysate,The difference of IFN-αlevels were significant with control groups,The content of IFN-αin intra-cell were higher than in ecto-cell,the difference was significant. The difference in 24h and 48h was not significant .IFN-γ、TFN-αwere detected in the supernatant and lysate,The difference was not significant with control groups,The difference in ecto-cell and intra-cell was not significant . The difference in 24h and 48hwas not significant.
3.2.2.15cells were treated with PPD、polyI:C and PHA with the maximal tolerance dosage,the effect of cleaning HbsAg and HBeAg was not significant with control groups.
Conclusion
1. IFN-αcan be Induced by PPD、polyI:C and PHA in HepG2 cell and then be secreted out;The content of IFN-αand action time were direct ratio. IFN-γcan be induced by PPD and PHA and then were not secreted out; The content of IFN-γand action time were independence. IFN-γcan be induced by polyI:C ,but the effect was not obviously. TNF-αcan be Induced byPPD、polyI:C and PHA but the effect was not obviously.
2. IFN-αcan be Induced by PPD、polyI:C and PHA in2.2.15 cell and then be secreted out ; The content of IFN-αand action time were independence. IFN-γ、TNF-αcan be induced by PPD、polyI:C and PHA but the effect was not obviously
3. 2.2.15 cells were treated with PPD、polyI:C and PHA,the effect of cleaning sAg and eAg was not significant.
在体外模型研究肝细胞能否被诱导产生干扰素等细胞因子,探讨肝细胞在乙型肝炎病毒清除过程中可能发挥的作用。
方法
选用聚肌胞(polyI:C)、植物血凝素(PHA)与结核菌素纯蛋白衍生物(PPD)为细胞因子诱生剂,以诱生剂最大无毒浓度刺激HepG2细胞及2.2.15细胞,分别以无细胞因子诱生剂作用的HepG2细胞及2.2.15细胞为对照组,用双抗体夹心ELlSA法检测细胞上清液及细胞裂解液中24小时、48小时IFN-α、TNF-α与IFN-γ的含量,并检测了2.2.15细胞被细胞因子诱生剂刺激后24小时、48小时细胞上清液及细胞裂解液中的HBV病毒标志物sAg、eAg的含量。
结果
1. PPD、polyI:C、PHA以最大无毒浓度分别是10μg/ml、20μg/ml、30μg/ml;刺激HepG2后24hr,48 hr时点HepG2培养上清液及裂解液中均能产生IFN-α,与对照组比较有显著性差异,其含量48hr时点大于24hr时点,胞内、胞外含量有显著性差异; PPD、polyI:C与PHA刺激HepG2后,细胞上清液及裂解液均检测出TNF-α,但与对照组比较无显著性差异,胞内胞外含量无显著性差异,不同时点间亦无显著性差异; PPD、PHA、PoLyI:C刺激后上清液中均检出IFN-γ,但与对照组比较无显著性差异,PPD、PHA刺激后细胞培养裂解液中检测出IFN-γ,与对照组比较有显著性差异,胞内、胞外含量有显著性差异;PoLyI:C刺激后培养细胞裂解液中检出IFN-γ,但与对照组比较无显著性差异,不同时点间无显著性差异;
2. PPD、polyI:C、PHA以最大无毒浓度,刺激2.2.15细胞后,细胞裂解液、上清液均检测出IFN-α,与对照组比较有显著性差异,胞内含量比胞外含量多,有显著性差异,不同时点间无显著性差异;细胞裂解液、上清液中均检出IFN-γ、TFN-α;但与对照组比较无显著性差异,胞内含量与胞外含量比,无显著性差异,不同时点间无显著性差异;
3. PPD、polyI:C、PHA以最大无毒浓度,刺激2.2.15细胞,细胞裂解液、上清液清除sAg、eAg的效果与对照组相比无显著性差异。
结论
1. PPD、polyI:C、PHA能够刺激HepG2细胞产生IFN-α并分泌至胞外,且IFN-α的量与诱生剂作用时间成正比。PPD、PHA能刺激HepG2细胞产生IFN-γ,但未能或未及分泌至胞外,IFN-γ的量与诱生剂作用时间长短无关。polyI:C刺激HepG2细胞产生IFN-γ作用不明显;另外,三种诱生剂刺激HepG2产生TNF-α作用也不明显。
2. PPD、polyI:C、PHA,刺激2.2.15细胞后,能产生IFN-α,并分泌至胞外,但IFN-α的量与诱生剂作用时间长短无关;三种诱生剂刺激2.2.15细胞产生IFN-γ、TNF-α作用均不明显。
3. PPD、polyI:C、PHA,刺激2.2.15细胞,清除sAg、eAg的效果不明显。
Objective
To investgate if cytokines can be Induced by cytokine Inducer in hepatocytes in vitro.
Methods
HepG2 and 2.2.15 Cells were treated with maximal tolerance dosage of polyI:C ,PHA, and PPD. After 24h and 48h ,the contents of IFN-α、TNF-αand IFN-γboth in the supernatant and cell were determined by ELISA, and the contents of HBV virus marker sAg、eAg in 2.2.15 Cells in the supernatant and cell were also determined by ELISA.
Results
1、IFN-αwere detected in the supernatant and lysate in 24h and 48h,IFN-αlevels were significantly higher than that of control groups,IFN-αlevels in 24h were significantly higher than in 48h,IFN-αlevels in intra-cell and ecto-cell were significant difference。HepG2 were treated with PPD、polyI:C and PHA, TNF-αwere detected in the supernatant and lysate, The difference of TNF-αlevels were not significant with control groups,The difference of IFN-αlevels in intra-cell and ecto-cell were not significant. The difference of IFN-αlevels in 24h and 48h were not significant. HepG2 were treated with PPD、polyI:C and PHA , IFN-γwere detected in the supernatant ,The difference of IFN-γlevels were not significant with control groups,HepG2 were treated with PPD and PHA,IFN-γwere detected in the lysate,The difference of IFN-γlevels were not significant with control groups,The difference of IFN-γlevels in 24h and 48h were not significant.
2. 2.2.15cells were treated with PPD、polyI:C and PHA with the maximal tolerance dosage,IFN-αwere detected in the supernatant and lysate,The difference of IFN-αlevels were significant with control groups,The content of IFN-αin intra-cell were higher than in ecto-cell,the difference was significant. The difference in 24h and 48h was not significant .IFN-γ、TFN-αwere detected in the supernatant and lysate,The difference was not significant with control groups,The difference in ecto-cell and intra-cell was not significant . The difference in 24h and 48hwas not significant.
3.2.2.15cells were treated with PPD、polyI:C and PHA with the maximal tolerance dosage,the effect of cleaning HbsAg and HBeAg was not significant with control groups.
Conclusion
1. IFN-αcan be Induced by PPD、polyI:C and PHA in HepG2 cell and then be secreted out;The content of IFN-αand action time were direct ratio. IFN-γcan be induced by PPD and PHA and then were not secreted out; The content of IFN-γand action time were independence. IFN-γcan be induced by polyI:C ,but the effect was not obviously. TNF-αcan be Induced byPPD、polyI:C and PHA but the effect was not obviously.
2. IFN-αcan be Induced by PPD、polyI:C and PHA in2.2.15 cell and then be secreted out ; The content of IFN-αand action time were independence. IFN-γ、TNF-αcan be induced by PPD、polyI:C and PHA but the effect was not obviously
3. 2.2.15 cells were treated with PPD、polyI:C and PHA,the effect of cleaning sAg and eAg was not significant.
引文
[1] 张定凤. 从机体清除乙型肝炎病毒的规律探讨抗病毒治疗的新策略。中华肝脏病杂志。2001,9(4):196-202
[2] Guidotti LG, Rochford R, Chung J, et al. Viral clearance without distruction of infected cells during acute HBV infection. Science, 1999,248:825-828.
[3] Heise T, Guidotti LG,Cavanaugh VJ, et al. Hepatitis B virus RNA-binding proteins associated with cytokine-induced clearance of viral RNA from the liver of transgenic mice. J Virol, 1999,73:474-481.
[4] Webster GJ, Reignat S, Maini MK,et al. Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology,2000,32(5): 1117-1124.
[5] McClary H, Koch R, Chisari FV,et al. Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines. Virol. 2000,74(5):2255-2264.
[6] Cavanaugh VJ, Guidotti LG,Chisari FV. Inhibition of hepatitis B virus replication during adenovirus and cytomegalovirus infection in transgenic mice.J Virol,1998,72:2630-2637.
[7] Wieland SF, Guidotti LG, Chisari FV.Intrahepatic induction of alpha/beta interfection eliminates viral RNA-containing capsides in hepatitis B virus transgenic mice .J virol,2000,74:4165-4173.
[8] Stonans I,Stonane E,Russwurm S, et al. HepG2 human hepatoma cells express multiple cytokine genes. Cytokine. 1999 ,11(2): 151-156.
[9] 张定风. 重新认识乙型肝炎防治中的几个问题[J]. 中华医学杂志,2000,80(1):5-6.
[10] 张定风. 肝细胞凋亡[J]. 中华消化杂志,1998,18(2):108-110.
[11] Guidotti LG,Borrow P, Brown A, et al. Noncytopathic clearance of lymphocytic choriomeningitis virus from the hepatocyte. J Exp Med,1999,189:1555-1564.
[12] Pasquetto V, Wieland SF, Uprichard SL,et al.Cytokine-sensitive replication of hepatitis B virus in immortalized mouse hepatocyte cultures. J-Virol, 2002, 76(11): 5646-5653.
[13] Gordien E, Rorsmorduc o, Peltekian C, et al. Inhibition of hepatitis B virus replication by interferon-inducible MxA protein. J virol, 2001,75(6):2684-2691.
[14] Heise T, Guidotti LG,Chisari FV,La autoantigen specifically recognizes a predicted stem-loop in hepatitis B virus replication in the liver of transgenic mice.J virol,,1999,73:5767-5776.
[15] Robek MD,Wieland SF, Chisari FV,et al.Inhibition of hepatitis B virus replication by interferon requires proteasome activity. J-Virol,2002,76(7): 3570-3574.
[16] Heise T, Guidotti LG, Chisari FV,et al.Characterization of nuclear RNases that cleave hepatitis B virus RNA near the La protein binding site. J Virol. 2001 ,75(15):6874-6883.
[17] Suri D, Schilling R, Lopes AR,et al.Non-cytolytic inhibition of hepatitis B virus replication in human hepatocytes. J-Hepatol. 2001, 35(6): 790-797.
[18] Guidotti LG, Morris A. Interferon-regulated pathways that control hepatitis B virus replication in transgenic miceJ Virol. 2002,76(6):2617-21.
[19] Wieland SF, Vega RG, Muller R, et al.Searching for interferon-induced genes that inhibit hepatitis B virus replication in transgenic mouse hepatocytes. J Virol. 2003 ,77(2):1227-1236.
[1] Cova L;Zoulim F. Duck hepatitis B virus model in the study of hepatitis B virus[J]. Methods Mol Med, 2004, 96:261-268
[2] Hantz O;Zoulim F. Duck hepatitis B virus primary hepatocyte culture model[J] Methods Mol Med, 2004, 96:189-197
[3] Gathuru JK;Koide F;Ragupathi G;Adams JL;Kerns RT;Coleman TP;Livingston PO. Identification of DHBcAg as a potent carrier protein comparable to KLH for augumenti -ng MUC1 antigenicity [J]. Vaccine, 2005,23: 4727-4733
[4] Sen N;Cao F;Tavis JE. Translation of duck hepatitis B virus reverse transcriptase by ribosomal shunting[J]. J Virol,2004,78: 11751-11757
[5] Schultz U;Grgacic E;Nassal M:Duck hepatitis B virus: an invaluable model system for HBV infection[J]. Adv Virus Res,2004,63:1-70
[6] Cova L,Hantz O,Arliaud_Gassin M,et al. Comparative study of DHBV DNA level a -nd endogenous DNA_p activity in naturally infected ducklings in France[J]. J Virol Method,1985,10:251
[7] Niu Jianzhang,Wang Yanyan,Qiao,et al.Effect of Phyllanthus amarus on duck hepa -titis B virus replication in vivo[J].J Med Virol,1990,32:212
[8] Leung KT;Chiu LC;Lam WS;Li Y;Sun SS;Ooi VE:In vitro antiviral activities of Chinese medicinal herbs against duck hepatitis B virus[J]. Phytother, Res,2006,20:911 -914
[9] Jim H, Wayne L G. Sequences required for self-catalysed cleavage of the satellite R -NA of tobacco ringspot virus. Gene,1989,82:43-52.
[10] Jim H,Wayne L G.Sigle RNA enzymes with new and highly specific endoribon -uclease activities. Nature,1988,334:585-591.
[11] Giovannangeli C and Helene C: Progress in developments of triplesbasedstriple -sbasedstrategies.Antisense-Nucleie-Acid-Dev, 1997, 7(4): 413-421
[12] Can PP and Glazer PM: Triplex DNA: fundancnials,advances,andpotential applic -ations for gene therapy. J Mol Med, 1997,75(4):267-268.
[13] Lin L,Hanson CV,Alter HJ,et al. Inactivation of viruses in platelet concentratesby photochemical treatment with amotosalen and long-wavelength ultraviolet light[J]. Transfusion,2005,45:580-590
[14] Steinmann J:Surrogate viruses for testing virucidal efficacy of chemical disinfetant –s[J].J Hosp Infect,2004, 56 (Suppl 2): 49-54
. [15] Sauerbrei A;Schacke M;Gluck B;Egerer R;Wutzler P:Validation of biocides again -st duck hepatitis B virus as a surrogate virus for human hepatitis B virus[J]. J Hosp Infe -ct,2006, 64(4):358-365.
[1] Guidotti LG. ,Rochford R. .Chung J Viral clearance without destruction of infected cells during acute HBV infection.Science.1999,2184:825-82995, 13(3):29-60
[2] Guidotti LG, Morris A. Interferon-regulated pathways that control hepatitis B virus replication in transgenic miceJ Virol. 2002,76(6):2617-2621.
[3] Suri D, Schilling R, Lopes AR,et al.Non-cytolytic inhibition of hepatitis B virus replication in human hepatocytes. J-Hepatol. 2001, 35(6): 790-797.
[4] Heise T, Guidotti LG, Cavanaugh VJ,et al.Hepatitis B virus RNA-binding proteins associated with cytokine-induced clearance of viral RNA from the liver of transgenic mice. J Virol. 1999,73(1):474-481.
[5] Heise T, Guidotti LG, Chisari FV,et al.Characterization of nuclear RNases that cleave hepatitis B virus RNA near the La protein binding site. J Virol. 2001 ,75(15):6874-6883.
[6] Wieland SF, Guidotti LG, Chisari FV,et al. Intrahepatic induction of alpha/beta interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice.J Virol. 2000 ,74(9):4165-4173.
[7] Pasquetto V, Wieland SF, Uprichard SL,et al.Cytokine-sensitive replication of hepatitis B virus in immortalized mouse hepatocyte cultures. J-Virol, 2002, 76(11): 5646-5653.
[8] Robek MD,Wieland SF, Chisari FV,et al.Inhibition of hepatitis B virus replication by interferon requires proteasome activity. J-Virol,2002,76(7): 3570-3574.
[9] Wieland SF, Vega RG, Muller R, et al.Searching for interferon-induced genes that inhibit hepatitis B virus replication in transgenic mouse hepatocytes. J Virol. 2003 ,77(2):1227-1236.
[10] Weiland SF,Guidotti LG.Chisari Fv.Intrahepatic induction of alpha/beta interferon eliminates vira.RNA - containing capsids in hepatitis B virus transgenic mice.J Virol.2000,74: 4165-4173
[11] de Veer MJ,Holko M, Frevel M,et al, Functional classification of interferon-stimulated genes identified using microarrays. J Leukoc Biol, 2001, 69: 912-920.
[12] McClary H, Koch R, Chisari FV,et al. Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines. Virol. 2000,74(5):2255-2264.
[13] Sauerbrei A;Schacke M;Gluck B;Egerer R;Wutzler P:Validation of biocides again -st duck hepatitis B virus as a surrogate virus for human hepatitis B virus[J]. J Hosp Infe -ct,2006, 64(4):358-365.
[14] Can PP and Glazer PM: Triplex DNA: fundancnials,advances,andpotential applic -ations for gene therapy. J Mol Med, 1997,75(4):267-268.
[2] Guidotti LG, Rochford R, Chung J, et al. Viral clearance without distruction of infected cells during acute HBV infection. Science, 1999,248:825-828.
[3] Heise T, Guidotti LG,Cavanaugh VJ, et al. Hepatitis B virus RNA-binding proteins associated with cytokine-induced clearance of viral RNA from the liver of transgenic mice. J Virol, 1999,73:474-481.
[4] Webster GJ, Reignat S, Maini MK,et al. Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology,2000,32(5): 1117-1124.
[5] McClary H, Koch R, Chisari FV,et al. Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines. Virol. 2000,74(5):2255-2264.
[6] Cavanaugh VJ, Guidotti LG,Chisari FV. Inhibition of hepatitis B virus replication during adenovirus and cytomegalovirus infection in transgenic mice.J Virol,1998,72:2630-2637.
[7] Wieland SF, Guidotti LG, Chisari FV.Intrahepatic induction of alpha/beta interfection eliminates viral RNA-containing capsides in hepatitis B virus transgenic mice .J virol,2000,74:4165-4173.
[8] Stonans I,Stonane E,Russwurm S, et al. HepG2 human hepatoma cells express multiple cytokine genes. Cytokine. 1999 ,11(2): 151-156.
[9] 张定风. 重新认识乙型肝炎防治中的几个问题[J]. 中华医学杂志,2000,80(1):5-6.
[10] 张定风. 肝细胞凋亡[J]. 中华消化杂志,1998,18(2):108-110.
[11] Guidotti LG,Borrow P, Brown A, et al. Noncytopathic clearance of lymphocytic choriomeningitis virus from the hepatocyte. J Exp Med,1999,189:1555-1564.
[12] Pasquetto V, Wieland SF, Uprichard SL,et al.Cytokine-sensitive replication of hepatitis B virus in immortalized mouse hepatocyte cultures. J-Virol, 2002, 76(11): 5646-5653.
[13] Gordien E, Rorsmorduc o, Peltekian C, et al. Inhibition of hepatitis B virus replication by interferon-inducible MxA protein. J virol, 2001,75(6):2684-2691.
[14] Heise T, Guidotti LG,Chisari FV,La autoantigen specifically recognizes a predicted stem-loop in hepatitis B virus replication in the liver of transgenic mice.J virol,,1999,73:5767-5776.
[15] Robek MD,Wieland SF, Chisari FV,et al.Inhibition of hepatitis B virus replication by interferon requires proteasome activity. J-Virol,2002,76(7): 3570-3574.
[16] Heise T, Guidotti LG, Chisari FV,et al.Characterization of nuclear RNases that cleave hepatitis B virus RNA near the La protein binding site. J Virol. 2001 ,75(15):6874-6883.
[17] Suri D, Schilling R, Lopes AR,et al.Non-cytolytic inhibition of hepatitis B virus replication in human hepatocytes. J-Hepatol. 2001, 35(6): 790-797.
[18] Guidotti LG, Morris A. Interferon-regulated pathways that control hepatitis B virus replication in transgenic miceJ Virol. 2002,76(6):2617-21.
[19] Wieland SF, Vega RG, Muller R, et al.Searching for interferon-induced genes that inhibit hepatitis B virus replication in transgenic mouse hepatocytes. J Virol. 2003 ,77(2):1227-1236.
[1] Cova L;Zoulim F. Duck hepatitis B virus model in the study of hepatitis B virus[J]. Methods Mol Med, 2004, 96:261-268
[2] Hantz O;Zoulim F. Duck hepatitis B virus primary hepatocyte culture model[J] Methods Mol Med, 2004, 96:189-197
[3] Gathuru JK;Koide F;Ragupathi G;Adams JL;Kerns RT;Coleman TP;Livingston PO. Identification of DHBcAg as a potent carrier protein comparable to KLH for augumenti -ng MUC1 antigenicity [J]. Vaccine, 2005,23: 4727-4733
[4] Sen N;Cao F;Tavis JE. Translation of duck hepatitis B virus reverse transcriptase by ribosomal shunting[J]. J Virol,2004,78: 11751-11757
[5] Schultz U;Grgacic E;Nassal M:Duck hepatitis B virus: an invaluable model system for HBV infection[J]. Adv Virus Res,2004,63:1-70
[6] Cova L,Hantz O,Arliaud_Gassin M,et al. Comparative study of DHBV DNA level a -nd endogenous DNA_p activity in naturally infected ducklings in France[J]. J Virol Method,1985,10:251
[7] Niu Jianzhang,Wang Yanyan,Qiao,et al.Effect of Phyllanthus amarus on duck hepa -titis B virus replication in vivo[J].J Med Virol,1990,32:212
[8] Leung KT;Chiu LC;Lam WS;Li Y;Sun SS;Ooi VE:In vitro antiviral activities of Chinese medicinal herbs against duck hepatitis B virus[J]. Phytother, Res,2006,20:911 -914
[9] Jim H, Wayne L G. Sequences required for self-catalysed cleavage of the satellite R -NA of tobacco ringspot virus. Gene,1989,82:43-52.
[10] Jim H,Wayne L G.Sigle RNA enzymes with new and highly specific endoribon -uclease activities. Nature,1988,334:585-591.
[11] Giovannangeli C and Helene C: Progress in developments of triplesbasedstriple -sbasedstrategies.Antisense-Nucleie-Acid-Dev, 1997, 7(4): 413-421
[12] Can PP and Glazer PM: Triplex DNA: fundancnials,advances,andpotential applic -ations for gene therapy. J Mol Med, 1997,75(4):267-268.
[13] Lin L,Hanson CV,Alter HJ,et al. Inactivation of viruses in platelet concentratesby photochemical treatment with amotosalen and long-wavelength ultraviolet light[J]. Transfusion,2005,45:580-590
[14] Steinmann J:Surrogate viruses for testing virucidal efficacy of chemical disinfetant –s[J].J Hosp Infect,2004, 56 (Suppl 2): 49-54
. [15] Sauerbrei A;Schacke M;Gluck B;Egerer R;Wutzler P:Validation of biocides again -st duck hepatitis B virus as a surrogate virus for human hepatitis B virus[J]. J Hosp Infe -ct,2006, 64(4):358-365.
[1] Guidotti LG. ,Rochford R. .Chung J Viral clearance without destruction of infected cells during acute HBV infection.Science.1999,2184:825-82995, 13(3):29-60
[2] Guidotti LG, Morris A. Interferon-regulated pathways that control hepatitis B virus replication in transgenic miceJ Virol. 2002,76(6):2617-2621.
[3] Suri D, Schilling R, Lopes AR,et al.Non-cytolytic inhibition of hepatitis B virus replication in human hepatocytes. J-Hepatol. 2001, 35(6): 790-797.
[4] Heise T, Guidotti LG, Cavanaugh VJ,et al.Hepatitis B virus RNA-binding proteins associated with cytokine-induced clearance of viral RNA from the liver of transgenic mice. J Virol. 1999,73(1):474-481.
[5] Heise T, Guidotti LG, Chisari FV,et al.Characterization of nuclear RNases that cleave hepatitis B virus RNA near the La protein binding site. J Virol. 2001 ,75(15):6874-6883.
[6] Wieland SF, Guidotti LG, Chisari FV,et al. Intrahepatic induction of alpha/beta interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice.J Virol. 2000 ,74(9):4165-4173.
[7] Pasquetto V, Wieland SF, Uprichard SL,et al.Cytokine-sensitive replication of hepatitis B virus in immortalized mouse hepatocyte cultures. J-Virol, 2002, 76(11): 5646-5653.
[8] Robek MD,Wieland SF, Chisari FV,et al.Inhibition of hepatitis B virus replication by interferon requires proteasome activity. J-Virol,2002,76(7): 3570-3574.
[9] Wieland SF, Vega RG, Muller R, et al.Searching for interferon-induced genes that inhibit hepatitis B virus replication in transgenic mouse hepatocytes. J Virol. 2003 ,77(2):1227-1236.
[10] Weiland SF,Guidotti LG.Chisari Fv.Intrahepatic induction of alpha/beta interferon eliminates vira.RNA - containing capsids in hepatitis B virus transgenic mice.J Virol.2000,74: 4165-4173
[11] de Veer MJ,Holko M, Frevel M,et al, Functional classification of interferon-stimulated genes identified using microarrays. J Leukoc Biol, 2001, 69: 912-920.
[12] McClary H, Koch R, Chisari FV,et al. Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines. Virol. 2000,74(5):2255-2264.
[13] Sauerbrei A;Schacke M;Gluck B;Egerer R;Wutzler P:Validation of biocides again -st duck hepatitis B virus as a surrogate virus for human hepatitis B virus[J]. J Hosp Infe -ct,2006, 64(4):358-365.
[14] Can PP and Glazer PM: Triplex DNA: fundancnials,advances,andpotential applic -ations for gene therapy. J Mol Med, 1997,75(4):267-268.